Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis

Journal of Virology

Volumn 83, Issue 19, 2009, Pages 9630-9640

  Johnson, Elizabeth M ^a   Doyle, Joshua D ^a   Wetzel, J Denise ^a   McClung, R Paul ^a   Katunuma, Nobuhiko ^b   Chappell, James D ^a   Washington, M Kay ^a,c   Dermody, Terence S ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CATHEPSIN B; CATHEPSIN L; CATHEPSIN S; CLIK 148; CYSTEINE PROTEINASE INHIBITOR; LEVO EPOXYSUCCINYL LEUCYLAMIDO (4 GUANIDINO)BUTANE; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BRAIN INFECTION; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; HEPATITIS; IN VITRO STUDY; IN VIVO STUDY; MORTALITY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REOVIRUS; SURVIVAL; VIREMIA; VIRION; VIROGENESIS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; VIRUS VIRULENCE; WEIGHT GAIN; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; BRAIN; CATHEPSIN B; CATHEPSINS; CELL LINE; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; REOVIRIDAE; REOVIRIDAE INFECTIONS; TIME FACTORS;

MAMMALIA; MIRIDAE; MUS; ORTHOREOVIRUS;

EID: 70349293676     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01095-09     Document Type: Article

References (89)

1. Antar, A. A. R., J. L. Konopka, J. A. Campbell, R. A. Henry, A. L. Perdigoto, B. D. Carter, A. Pozzi, T. W. Abel, and T. S. Dermody. 2009. Junctional adhesion molecule-A is required for hematogenous dissemination of reovirus. Cell Host Microbe 5:59-71.
2. Baer, G. S., and T. S. Dermody. 1997. Mutations in reovirus outer-capsid protein σ3 selected during persistent infections of L cells confer resistance to protease inhibitor E64. J. Virol. 71:4921-4928.
3. Barrett, A. J., A. A. Kembhavi, M. A. Brown, H. Kirschke, C. G. Knight, M. Tamai, and K. Hanada. 1982. L-trans-Epoxysuccinyl-leucylamido(4-guanidino) butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. 201:189-198.
4. Barton, E. S., J. L. Connolly, J. C. Forrest, J. D. Chappell, and T. S. Dermody. 2001. Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J. Biol. Chem. 276:2200-2211.
5. Barton, E. S., B. E. Youree, D. H. Ebert, J. C. Forrest, J. L. Connolly, T. Valyi-Nagy, K. Washington, J. D. Wetzel, and T. S. Dermody. 2003. Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J. Clin. Investig. 111:1823-1833.
6. Borsa, J., B. D. Morash, M. D. Sargent, T. P. Copps, P. A. Lievaart, and J. G. Szekely. 1979. Two modes of entry of reovirus particles into L cells. J. Gen. Virol. 45:161-170.
7. Borsa, J., M. D. Sargent, P. A. Lievaart, and T. P. Copps. 1981. Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology 111:191-200. (Pubitemid 11047689)
8. Bromme, D., and J. Kaleta. 2002. Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor design. Curr. Pharm. Des. 8:1639-1658.
9. Bromme, D., A. Steinert, S. Friebe, S. Fittkau, B. Wiederanders, and H. Kirschke. 1989. The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B. Biochem. J. 264:475-481.
10. Carmona, E., É. Dufour, C. Plouffe, S. Takebe, P. Mason, J. S. Mort, and R. Ménard. 1996. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry 35:8149-8157. (Pubitemid 26234914)
11. Chandran, K., D. L. Farsetta, and M. L. Nibert. 2002. Strategy for non-enveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein μ1 mediates membrane disruption. J. Virol. 76:9920-9933. (Pubitemid 35006531)
12. Chandran, K., J. S. Parker, M. Ehrlich, T. Kirchhausen, and M. L. Nibert. 2003. The δ region of outer-capsid protein μ1 undergoes conformational change and release from reovirus particles during cell entry. J. Virol. 77:13361-13375. (Pubitemid 37494330)
13. Chandran, K., N. J. Sullivan, U. Felbor, S. P. Whelan, and J. M. Cunningham. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645. (Pubitemid 40807517)
14. Chang, C. T., and H. J. Zweerink. 1971. Fate of parental reovirus in infected cell. Virology 46:544-555.
15. Chapman, H. A. 2006. Endosomal proteases in antigen presentation. Curr. Opin. Immunol. 18:78-84.
16. Chapman, H. A., R. J. Riese, and G. P. Shi. 1997. Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59:63-88.
17. Clark, K. M., J. D. Wetzel, J. Bayley, D. H. Ebert, S. A. McAbee, E. K. Stoneman, G. S. Baer, Y. Zhu, G. J. Wilson, B. V. V. Prasad, and T. S. Dermody. 2006. Reovirus variants selected for resistance to ammonium chloride have mutations in viral outer-capsid protein σ3. J. Virol. 80:671-681.
18. Danthi, P., C. M. Coffey, J. S. Parker, T. W. Abel, and T. S. Dermody. 2008. Independent regulation of reovirus membrane penetration and apoptosis by the μ1 φ domain. PLoS Pathog. 4:e1000248. (Pubitemid 350309133)
19. Dermody, T. S., M. L. Nibert, J. D. Wetzel, X. Tong, and B. N. Fields. 1993. Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J. Virol. 67:2055-2063.
20. Derrien, M., J. W. Hooper, and B. N. Fields. 2003. The M2 gene segment is involved in the capacity of reovirus type 3Abney to induce the oily fur syndrome in neonatal mice, a S1 gene segment-associated phenotype. Virology 305:25-30. (Pubitemid 36062808)
21. Deussing, J., W. Roth, P. Saftig, C. Peters, H. L. Ploegh, and J. A. Villadangos. 1998. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. USA 95:4516-4521.
22. Diederich, S., L. Thiel, and A. Maisner. 2008. Role of endocytosis and cathepsin-mediated activation in Nipah virus entry. Virology 375:391-400.
23. Ebert, D. H., J. Deussing, C. Peters, and T. S. Dermody. 2002. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J. Biol. Chem. 277:24609-24617.
24. Ehrlich, M., W. Boll, A. Van Oijen, R. Hariharan, K. Chandran, M. L. Nibert, and T. Kirchhausen. 2004. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 118:591-605. (Pubitemid 39179712)
25. Fleeton, M., N. Contractor, F. Leon, J. D. Wetzel, T. S. Dermody, and B. Kelsall. 2004. Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J. Exp. Med. 200:235-245.
26. Funkelstein, L., T. Toneff, C. Mosier, S. R. Hwang, F. Beuschlein, U. D. Lichtenauer, T. Reinheckel, C. Peters, and V. Hook. 2008. Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expression. J. Biol. Chem. 283:35652-35659.
27. Furlong, D. B., M. L. Nibert, and B. N. Fields. 1988. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J. Virol. 62:246-256.
28. Golden, J. W., J. A. Bahe, W. T. Lucas, M. L. Nibert, and L. A. Schiff. 2004. Cathepsin S supports acid-independent infection by some reoviruses. J. Biol. Chem. 279:8547-8557.
29. Guicciardii, M. E., J. Deussing, H. Miyoshi, S. F. Bronk, P. A. Svingen, C. Peters, S. H. Kaufmann, and G. J. Gores. 2000. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Investig. 106:1127-1137.
30. Halangk, W., M. Lerch, B. Brandt-Nedelev, W. Roth, M. Ruthenbuerger, T. Reinheckel, W. Domschke, H. Lippert, C. Peters, and J. Deussing. 2000. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Investig. 106:773-781.
31. Haque, A., N. L. Banik, and S. K. Ray. 2008. New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics. CNS Neurol. Disord. Drug Targets 7:270-277.
32. Honey, K., K. Benlagha, C. Beers, K. Forbush, L. Teyton, M. J. Kleijmeer, A. Y. Rudensky, and A. Bendelac. 2002. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 3:1069-1074.
33. Honey, K., T. Nakagawa, C. Peters, and A. Rudensky. 2002. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J. Exp. Med. 195:1349-1358.
34. Hsieh, C. S., P. deRoos, K. Honey, C. Beers, and A. Y. Rudensky. 2002. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. J. Immunol. 168:2618-2625.
35. Hsing, L. C., and A. Y. Rudensky. 2005. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207:229-241.
36. Huang, I.-C., B. J. Bosch, F. Li, W. Li, K. H. Lee, S. Ghiran, N. Vasilieva, T. S. Dermody, S. C. Harrison, P. R. Dormitzer, M. Farzan, P. J. Rottier, and H. Choe. 2006. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 281:3198-3203.
37. Katunuma, N., E. Murata, H. Kakegawa, A. Matsui, H. Tsuzuki, H. Tsuge, D. Turk, V. Turk, M. Fukushima, Y. Tada, and T. Asao. 1999. Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo. FEBS Lett. 458:6-10. (Pubitemid 29415661)
38. Katunuma, N., H. Tsuge, M. Nukatsuka, T. Asao, and M. Fukushima. 2002. Structure-based design of specific cathepsin inhibitors and their application to protection of bone metastases of cancer cells. Arch. Biochem. Biophys. 397:305-311.
39. Kirschke, H., B. Wiederanders, D. Bromme, and A. Rinne. 1989. Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochem. J. 264:467-473.
40. Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J. P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, N. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J. C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R. H. Waterston, R. K. Wilson, L. W. Hillier, J. D. McPherson, M. A. Marra, E. R. Mardis, L. A. Fulton, A. T. Chinwalla, K. H. Pepin, W. R. Gish, S. L. Chissoe, M. C. Wendl, K. D. Delehaunty, T. L. Miner, A. Delehaunty, J. B. Kramer, L. L. Cook, R. S. Fulton, D. L. Johnson, P. J. Minx, S. W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J. F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921. (Pubitemid 32165345)
41. Lee, P. W. K., E. C. Hayes, and W. K. Joklik. 1981. Protein σ1 is the reovirus cell attachment protein. Virology 108:156-163.
42. Lutgens, S. P., K. B. Cleutjens, M. J. Daemen, and S. Heeneman. 2007. Cathepsin cysteine proteases in cardiovascular disease. FASEB J. 21:3029-3041. (Pubitemid 47565524)
43. Maehr, R., J. D. Mintern, A. E. Herman, A. M. Lennon-Dumenil, D. Mathis, C. Benoist, and H. L. Ploegh. 2005. Cathepsin L is essential for onset of autoimmune diabetes in NOD mice. J. Clin. Investig. 115:2934-2943.
44. Mann, M. A., D. M. Knipe, G. D. Fischbach, and B. N. Fields. 2002. Type 3 reovirus neuroinvasion after intramuscular inoculation: direct invasion of nerve terminals and age-dependent pathogenesis. Virology 303:222-231.
45. Marsh, M., and A. Helenius. 2006. Virus entry: open sesame. Cell 124:729-740.
46. Matsunaga, Y., T. Saibara, H. Kido, and N. Katunuma. 1993. Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett. 324:325-330. (Pubitemid 23172153)
47. Meulendyke, K. A., M. A. Wurth, R. O. McCann, and R. E. Dutch. 2005. Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein. J. Virol. 79:12643-12649. (Pubitemid 41433183)
48. Mizuochi, T., S. T. Yee, M. Kasai, T. Kakiuchi, D. Muno, and E. Kominami. 1994. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Immunol. Lett. 43:189-193.
49. Mohamed, M. M., and B. F. Sloane. 2006. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6:764-775.
50. Moriyama, T., M. Wada, R. Urade, M. Kito, N. Katunuma, T. Ogawa, and R. D. Simoni. 2001. 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum. Arch. Biochem. Biophys. 386:205-212.
51. Morrison, L. A., R. L. Sidman, and B. N. Fields. 1991. Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc. Natl. Acad. Sci. USA 88:3852-3856.
52. Nakagawa, T., W. Roth, P. Wong, A. Nelson, A. Farr, J. Deussing, J. A. Villadangos, H. Ploegh, C. Peters, and A. Y. Rudensky. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280:450-453. (Pubitemid 28208170)
53. Nakagawa, T. Y., W. H. Brissette, P. D. Lira, R. J. Griffiths, N. Petrushova, J. Stock, J. D. McNeish, S. E. Eastman, E. D. Howard, S. R. Clarke, E. F. Rosloniec, E. A. Elliott, and A. Y. Rudensky. 1999. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10:207-217.
54. Nibert, M. L., A. L. Odegard, M. A. Agosto, K. Chandran, and L. A. Schiff. 2005. Putative autocleavage of reovirus μ1 protein in concert with outercapsid disassembly and activation for membrane permeabilization. J. Mol. Biol. 345:461-474.
55. Odegard, A. L., K. Chandran, X. Zhang, J. S. Parker, T. S. Baker, and M. L. Nibert. 2004. Putative autocleavage of outer capsid protein μ1, allowing release of myristoylated peptide μ1N during particle uncoating, is critical for cell entry by reovirus. J. Virol. 78:8732-8745.
56. O'Donnell, S. M., M. W. Hansberger, J. L. Connolly, J. D. Chappell, M. J. Watson, J. M. Pierce, J. D. Wetzel, W. Han, E. S. Barton, J. C. Forrest, T. Valyi-Nagy, F. E. Yull, T. S. Blackwell, J. N. Rottman, B. Sherry, and T. S. Dermody. 2005. Organ-specific roles for transcription factor NF-κB in reovirus-induced apoptosis and disease. J. Clin. Investig. 115:2341-2350.
57. Pager, C. T., W. W. Craft, Jr., J. Patch, and R. E. Dutch. 2006. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 346:251-257.
58. Pager, C. T., and R. E. Dutch. 2005. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J. Virol. 79:12714-12720. (Pubitemid 41433191)
59. Papadimitriou, J. M. 1968. The biliary tract in acute murine reovirus 3 infection. Am. J. Pathol. 52:595-601.
60. Parashar, K., M. J. Tarlow, and M. A. McCrae. 1992. Experimental reovirus type 3-induced murine biliary tract disease. J. Pediatr. Surg. 27:843-847.
61. Petanceska, S., P. Canoll, and L. A. Devi. 1996. Expression of rat cathepsin S in phagocytic cells. J. Biol. Chem. 271:4403-4409.
62. Phillips, P. A., D. Keast, J. M. Papadimitriou, M. N. Walters, and N. F. Stanley. 1969. Chronic obstructive jaundice induced by reovirus type 3 in weanling mice. Pathology 1:193-203.
63. Pluger, E. B., M. Boes, C. Alfonso, C. J. Schroter, H. Kalbacher, H. L. Ploegh, and C. Driessen. 2002. Specific role for cathepsin S in the generation of antigenic peptides in vivo. Eur. J. Immunol. 32:467-476.
64. Porotto, M., G. Orefice, C. Yokoyama, B. Mungall, R. Realubit, M. Sganga, M. Aljofan, M. Whitt, F. Glickman, and A. Moscona. 2009. Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy. J. Virol. 83:5148-5155.
65. Reinheckel, T., J. Deussing, W. Roth, and C. Peters. 2001. Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol. Chem. 382:735-741.
66. Richardson, B. A., and J. Overbaugh. 2005. Basic statistical considerations in virological experiments. J. Virol. 79:669-676.
67. Riese, R. J., G. P. Shi, J. Villadangos, D. Stetson, C. Driessen, A. M. Lennon-Dumenil, C. L. Chu, Y. Naumov, S. M. Behar, H. Ploegh, R. Locksley, and H. A. Chapman. 2001. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. Immunity 15:909-919.
68. Roth, W., J. Deussing, V. Botchkarev, M. Pauly-Evers, P. Saftig, A. Hafner, P.Schmidt, W. Schmahl, J. Scherer, I. Anton-Lamprechet, K. Von Figura, R. Paus, and C. Peters. 2000. Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and perturbation of hair follicle cycling. FASEB J. 14:2075-2086. (Pubitemid 30747263)
69. Rubin, D. H., and B. N. Fields. 1980. Molecular basis of reovirus virulence: role of the M2 gene. J. Exp. Med. 152:853-868.
70. Schiff, L. A., M. L. Nibert, and K. L. Tyler. 2007. Orthoreoviruses and their replication, p. 1853-1915. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed., vol.2. Lippincott Williams & Wilkins, Philadelphia, PA.
71. Shen, L., L. J. Sigal, M. Boes, and K. L. Rock. 2004. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21:155-165. (Pubitemid 39094046)
72. Shi, G. P., J. S. Munger, J. P. Meara, D. H. Rich, and H. A. Chapman. 1992. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267:7258-7262.
73. Shi, G. P., A. C. Webb, K. E. Foster, J. H. Knoll, C. A. Lemere, J. S. Munger, and H. A. Chapman. 1994. Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J. Biol. Chem. 269:11530-11536.
74. Silverstein, S. C., C. Astell, D. H. Levin, M. Schonberg, and G. Acs. 1972. The mechanism of reovirus uncoating and gene activation in vivo. Virology 47:797-806.
75. Simmons, G., D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, and P. Bates. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA 102:11876-11881.
76. Sturzenbecker, L. J., M. L. Nibert, D. B. Furlong, and B. N. Fields. 1987. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J. Virol. 61:2351-2361.
77. Tardieu, M., M. L. Powers, and H. L. Weiner. 1983. Age-dependent susceptibility to reovirus type 3 encephalitis: role of viral and host factors. Ann. Neurol. 13:602-607.
78. Turk, V., B. Turk, and D. Turk. 2001. Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20:4629-4633. (Pubitemid 32848615)
79. Tyler, K. L., E. S. Barton, M. L. Ibach, C. Robinson, T. Valyi-Nagy, J. A. Campbell, P. Clarke, S. M. O'Donnell, J. D. Wetzel, and T. S. Dermody. 2004. Isolation and molecular characterization of a novel type 3 reovirus from a child with meningitis. J. Infect. Dis. 189:1664-1675.
80. Tyler, K. L., R. T. Bronson, K. B. Byers, and B. N. Fields. 1985. Molecular basis of viral neurotropism: experimental reovirus infection. Neurology 35:88-92.
81. Vasiljeva, O., T. Reinheckel, C. Peters, D. Turk, V. Turk, and B. Turk. 2007. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr. Pharm. Des. 13:387-403.
82. Venter, J. C., M. D. Adams, E. W. Myers, P. W. Li, R. J. Mural, G. G. Sutton, H. O. Smith, M. Yandell, C. A. Evans, R. A. Holt, J. D. Gocayne, P. Amanatides, R. M. Ballew, D. H. Huson, J. R. Wortman, Q. Zhang, C. D. Kodira, X. H. Zheng, L. Chen, M. Skupski, G. Subramanian, P. D. Thomas, J. Zhang, G. L. Gabor Miklos, C. Nelson, S. Broder, A. G. Clark, J. Nadeau, V. A. McKusick, N. Zinder, A. J. Levine, R. J. Roberts, M. Simon, C. Slayman, M. Hunkapiller, R. Bolanos, A. Delcher, I. Dew, D. Fasulo, M. Flanigan, L. Florea, A. Halpern, S. Hannenhalli, S. Kravitz, S. Levy, C. Mobarry, K. Reinert, K. Remington, J. Abu-Threideh, E. Beasley, K. Biddick, V. Bonazzi, R. Brandon, M. Cargill, I. Chandramouliswaran, R. Charlab, K. Chaturvedi, Z. Deng, V. Di Francesco, P. Dunn, K. Eilbeck, C. Evangelista, A. E. Gabrielian, W. Gan, W. Ge, F. Gong, Z. Gu, P. Guan, T. J. Heiman, M. E. Higgins, R. R. Ji, Z. Ke, K. A. Ketchum, Z. Lai, Y. Lei, Z. Li, J. Li, Y. Liang, X. Lin, F. Lu, G. V. Merkulov, N. Milshina, H. M. Moore, A. K. Naik, V. A. Narayan, B. Neelam, D. Nusskern, D. B. Rusch, S. Salzberg, W. Shao, B. Shue, J. Sun, Z. Wang, A. Wang, X. Wang, J. Wang, M. Wei, R. Wides, C. Xiao, C. Yan, et al. 2001. The sequence of the human genome. Science 291:1304-1351.
83. Virgin, H. W., IV, R. Bassel-Duby, B. N. Fields, and K. L. Tyler. 1988. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J. Virol. 62:4594-4604.
84. Virgin, H. W., K. L. Tyler, and T. S. Dermody. 1997. Reovirus, p. 669-699. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven, New York, NY.
85. Weiner, H. L., K. A. Ault, and B. N. Fields. 1980. Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J. Immunol. 124:2143-2148.
86. Wetzel, J. D., G. J. Wilson, G. S. Baer, L. R. Dunnigan, J. P. Wright, D. S. H. Tang, and T. S. Dermody. 1997. Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J. Virol. 71:1362-1369.
87. Wilson, G. A., L. A. Morrison, and B. N. Fields. 1994. Association of the reovirus S1 gene with serotype 3-induced biliary atresia in mice. J. Virol. 68:6458-6465. (Pubitemid 24294896)
88. Yang, M., Y. Zhang, J. Pan, J. Sun, J. Liu, P. Libby, G. K. Sukhova, A. Doria, N. Katunuma, O. D. Peroni, M. Guerre-Millo, B. B. Kahn, K. Clement, and G. P. Shi. 2007. Cathepsin L activity controls adipogenesis and glucose tolerance. Nat. Cell Biol. 9:970-977.
89. Yasuda, Y., J. Kaleta, and D. Bromme. 2005. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv. Drug Deliv. Rev. 57:973-993.